Nalaganje...
Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells
Novel approaches to pre-transplant conditioning are needed to improve treatment of advanced T-cell malignancies. We investigated the synergism of fludarabine (Flu), clofarabine (Clo), busulfan (Bu), and romidepsin (Rom) in T-cell lines and patient-derived cell samples. [Flu+Clo+Bu+Rom] had combinati...
Shranjeno v:
| izdano v: | Leuk Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4961533/ https://ncbi.nlm.nih.gov/pubmed/27294334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2016.05.019 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|